Los Angeles, California, May 13, 2010 — Three women from three countries, Emily Tarsell; United States, Judy Wilyman; Australia, and Freda Birrell; United Kingdom/Scotland, are actively educating their respective governments about Gardasil®, Cervarix® and Cervical Cancer.
Judy Wilyman Ph.D. is lecturer and researcher at Murdoch University in environmental health. The Australian Vaccination Network (AVN) asked if she would provide HPV vaccine facts for a brochure to show real risks of HPV infection and of cervical cancer. Judy states the literature clearly shows an infection with HPV 16 or 18 is no indication that a woman is likely to get cervical cancer.
Educate Before You Vaccinate Cervical Cancer/HPV brochure.
Facts on the Risk of Cervical Cancer and Use of Gardasil® Vaccine
Facts about the Disease
- 1. In 2004, the death rate from cervical cancer in Australia was 1.9/100,000 women; a very low risk to women
- 2. Infection with Human Papillomavirus (HPV) is not an indication you will get cervical cancer. 80% of women will be infected with HPV but 90% will show no clinical symptoms.
- 3. Lifetime risk of dying from cervical cancer in developed countries is approx. 0.25%.
- 4. The incidence of HPV 16/18 globally does not vary with the incidence of cervical cancer. Prevalence of HPV 16 is similar in all countries but 80% of cervical cancer occurs in developing countries.
- 5. Sexual behavior conducive to the acquisition of sexually transmitted infectious diseases increases a women’s risk of developing cervical cancer
- 6. Agent, host and environment all play a role in the development of disease.
- 7. Multiple partners for men and women are a risk factor for cervical cancer. Prostitutes are a known high risk group and sex without condoms increases the risk.
- 8. Scientists admit that HPV on its own does not cause cervical cancer. A co-factor is needed to trigger cancer eg. another virus – HSV-2, dietary factors or oral contraceptives.
- 9. The Australian Health Department calls this drug an HPV vaccine not a cervical cancer vaccine
- 10. There are 20 strains of HPV associated with cancer but only 2 covered in the vaccine.
Trials of the Vaccine
- 1. Trials did not observe that it would prevent any cervical cancer
- 2. Researchers were observing the incidence of precancerous lesions in 16-26 year old women – an age
group that rarely gets cervical cancer.
- 3. In young women pre-cancerous lesions are known to have a high clearance rate.
- 4. Commonwealth Serum Laboratories (pharmaceutical company) funded this research at the Cancer and Immunology Research Centre at the University of Queensland
- 5. Trials of the vaccine were funded by Merck
- 6. 10 of the authors of the trials were employed by Merck and the company has financial arrangements
- 1. It is a genetically modified vaccine
- 2. It contains 225 micrograms of aluminum adjuvant; more than most vaccines and known to cause
allergies/anaphylaxis and autoimmune reactions in humans
For more information go to Australian Vaccine Network
Other press releases from Bobbi Cowan Public Relations
- Creating Markets Out of Thin Air TruthAboutGardasil Creates Vaccine Awareness Movement in Response to Merck’s Award Winning HPV Campaign - June 30th, 2010
- Report Concerning Survey of Adverse Events Following Inoculations with Gardasil® - June 28th, 2010
- Merck wants your Tired, your Poor to be 'One Less' Gardasil Access Program Targets Third World Countries - June 24th, 2010
- Immediate Action to Prevent Cervical Cancer Deaths Key to Achieving Women's Health Goals Trial and Error: Ethical Violations of HPV Vaccination Trials in India - June 21st, 2010
- "What is Wrong with the Gardasil Girls Courtney's Story" - June 16th, 2010
Contact InformationBobbi Cowan
Bobbi Cowan Public Relations
Phone: (818) 980-2372